Pattern of failure and clinical value of local therapy for oligo‐recurrence in locally advanced non‐small cell lung cancer after definitive chemoradiation: Impact of driver mutation status-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pattern of failure and clinical value of local therapy for oligo‐recurrence in locally advanced non‐small cell lung cancer after definitive chemoradiation: Impact of driver mutation status

Published:2022-12-16 Issue:6 Volume:12 Page:6971-6979
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Zhang Jinmeng¹²^ORCID,Mao Jiuang¹²,Xu Dayu¹²,Jiang Shanshan¹²^ORCID,Guo Tiantian¹²,Zhou Yue¹²,Chu Li¹²,Yang Xi¹²,Chu Xiao¹²,Ni Jianjiao¹²,Zhu Zhengfei¹²³⁴⁵^ORCID

Affiliation:

1. Department of Radiation Oncology Fudan University Shanghai Cancer Center Shanghai China

2. Department of Oncology, Shanghai Medical College Fudan University Shanghai China

3. Institute of Thoracic Oncology Fudan University Shanghai China

4. Shanghai Clinical Research Center for Radiation Oncology Shanghai China

5. Shanghai Key Laboratory of Radiation Oncology Shanghai China

Funder

Beijing Xisike Clinical Oncology Research Foundation

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5493

Reference42 articles.

1. Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

2. Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

3. Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy

4. Role of Consolidation Durvalumab in Patients With EGFR- and HER2-Mutant Unresectable Stage III NSCLC

5. Evaluation of concurrent chemoradiotherapy for locally advanced NSCLC according to EGFR mutation status

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complex situations in lung cancer: multifocal disease, oligoprogression and oligorecurrence;European Respiratory Review;2024-04-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3